Lucentis approved for diabetic retinopathy

February 9, 2015

(HealthDay)—A drug to treat the most common eye disease among diabetics has been approved by the U.S. Food and Drug Administration.

Lucentis (ranibizumab) has been sanctioned to treat , the leading cause of blindness among adults in the United States, the FDA said in a news release. In 2008, one-third of diabetic adults 40 or older had some form of diabetic retinopathy, the agency said.

Lucentis, a once-monthly injection, is designed to be used with other therapies to control blood sugar, blood pressure and cholesterol, the FDA said. In some people with diabetic retinopathy who also have , can grow and rupture on the eye's retina, leading to severe vision loss or blindness.

The most common side effects of Lucentis include bleeding of the eye's conjunctiva, eye pain, eye floaters and increased eye pressure. More serious adverse reactions could include eye infection and retinal detachment, the FDA said.

Lucentis had been approved previously to treat other forms of macular edema, and .

The drug is marketed by San Francisco-based Genentech, a subsidiary of Roche.

Explore further: FDA approves drug to treat diabetic macular edema

More information: To learn more about this approval, visit the FDA.

Related Stories

FDA approves drug to treat diabetic macular edema

August 13, 2012
The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...

In mice and men: Laser treatment reverses effects of early age-related macular degeneration

February 2, 2015
A new technique reported in the February 2015 issue of The FASEB Journal suggests that during early stages, it might be possible to reverse age-related macular degeneration, a leading cause of blindness that is currently ...

Diabetes leading to blindness in many people

November 30, 2012
Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, ...

Sharp rise in diabetic eye disease makes American Diabetes Month ever more important

November 7, 2012
Diabetes is the leading cause of blindness among working-age adults in the United States. According to recent studies funded by the National Eye Institute (NEI), diabetic retinopathy, one of the most common and debilitating ...

FDA warns of another compounding pharmacy recall

March 20, 2013
(AP)—The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.

Blood vessel research offers insights into new treatments for eye diseases

May 27, 2014
(Medical Xpress)—Leukaemia drugs could help to improve treatments for blindness caused by abnormal blood vessel growth in the eye, finds new UCL research. The study, published in the Journal of Experimental Medicine, raises ...

Recommended for you

Research reveals da Vinci's genius may have been partly due to eye condition

October 19, 2018
Leonardo da Vinci may have had an eye condition that gave him an unusual ability to recreate three-dimensional shapes in his sculptures and paintings, according to new research.

Eating leafy greens could help prevent macular degeneration

October 19, 2018
A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD).

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

Gene therapy breakthrough in treating rare form of blindness

October 9, 2018
Positive results of the world's first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in Nature Medicine.

Gene changes driving myopia reveal new focus for drug development

October 9, 2018
Myopia (nearsightedness) and hyperopia (farsightedness) develop through different molecular pathways, according to a new study publishing October 9 in the open-access journal PLOS Biology by Andrei Tkatchenko of Columbia ...

Dynamin-binding protein linked to congenital cataracts

October 4, 2018
Cataracts, a condition in which the eyes' natural lenses get clouded, are the most common cause of vision loss in older people and can be corrected by routine surgery. But congenital cataracts, which occur in infants and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.